UBS Group’s Genpact G Stock Holding History

UBS Group’s Portfolio G Stock Details G Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-71,000	Closed	-$1.7M	–	7857
2016 Q3	$1.7M	Buy	+71,000	New	+$1.76M	﹤0.01%	2992

Other funds holding G

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NIEF

Nalanda India Equity Fund Mauritius $377M AUM 37.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group's G Position: Q2 2026 in Review

UBS Group reduced its Genpact (G) stake by 28% in Q2 2026, selling an estimated $17M and leaving 1,349,273 shares worth $37.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2053.

UBS Group first reported a position in G in Q4 2014 and has held it in 47 quarters since. The position peaked at $69.5M in Q1 2026. 479 funds tracked by Wall St. Rank hold G as of Q2 2026.

UBS Group held 1,349,273 shares of Genpact worth $37.1M as of Q2 2026.
UBS Group sold 517,564 Genpact shares in Q2 2026, an estimated $17M.
Genpact made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2053 holding.
UBS Group first reported a position in Genpact in Q4 2014 and has held it in 47 quarters since.
UBS Group's Genpact position peaked at $69.5M in Q1 2026.
479 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.